ADAP

Adaptimmune Therapeutics

49 hedge funds and large institutions have $103M invested in Adaptimmune Therapeutics in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 12 closing their positions.

Holders
49
Holders Change
-10
Holders Change %
-16.95%
% of All Funds
1.08%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
12
Reduced
14
Closed
12
Calls
$29K
Puts
Net Calls
+$29K
Net Calls Change
-$56K